1. Antibody-drug conjugates come of age in oncology;Dumontet;Nat. Rev. Drug Discovery,2023
2. Approval summary: gemtuzumab ozogamicin in relapsed acute myeloid leukemia;Bross;Clin. Cancer Res.,2001
3. Strategies and challenges for the next generation of therapeutic antibodies;Beck;Nat. Rev. Immunol.,2010
4. Seattle Genetics' Antibody-Drug Conjugate Receives FDA Okay to Treat Lymphomas;Genetic Engineering & Biotechnology News,2011
5. "FDA approves new treatment for late-stage breast cancer" (Press release). U.S. Food and Drug Administration (FDA). https://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm340704.htm 22 February 2013.